These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 38239190)

  • 21. Arachidonic acid metabolism as a novel pathogenic factor in gastrointestinal cancers.
    Lu W; Aihaiti A; Abudukeranmu P; Liu Y; Gao H
    Mol Cell Biochem; 2024 Jul; ():. PubMed ID: 38963615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
    Hernandez JJ; Pryszlak M; Smith L; Yanchus C; Kurji N; Shahani VM; Molinski SV
    Front Oncol; 2017; 7():273. PubMed ID: 29184849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions.
    Fu L; Jin W; Zhang J; Zhu L; Lu J; Zhen Y; Zhang L; Ouyang L; Liu B; Yu H
    Acta Pharm Sin B; 2022 Feb; 12(2):532-557. PubMed ID: 35256933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug Repurposing for Retinoblastoma: Recent Advances.
    Dandu K; Kallamadi PR; Thakur SS; Rao CM
    Curr Top Med Chem; 2019; 19(17):1535-1544. PubMed ID: 30659544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug repositioning for esophageal squamous cell carcinoma.
    Bennett AN; Huang RX; He Q; Lee NP; Sung WK; Chan KHK
    Front Genet; 2022; 13():991842. PubMed ID: 36246638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Repurposing: Insights into Current Advances and Future Applications.
    Bhatia T; Sharma S
    Curr Med Chem; 2023 Nov; ():. PubMed ID: 37946344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
    Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug repositioning for personalized medicine.
    Li YY; Jones SJ
    Genome Med; 2012; 4(3):27. PubMed ID: 22494857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug repurposing for breast cancer therapy: Old weapon for new battle.
    Aggarwal S; Verma SS; Aggarwal S; Gupta SC
    Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.
    Haddad P; Mir MR; Jamali M; Abdirad A; Alikhasi A; Farhan F; Memari F; Sadighi S; Shahi F
    Acta Med Iran; 2013 May; 51(4):270-3. PubMed ID: 23690109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting.
    Gholami S; Abidalhassan M; Cho M; Saeed A; Rocha FG
    J Gastrointest Cancer; 2023 Jun; 54(2):672-676. PubMed ID: 35856132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients.
    Al-Odat OS; Nelson E; Budak-Alpdogan T; Jonnalagadda SC; Desai D; Pandey MK
    Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
    Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
    Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Repurposing in Cancer Therapy: Influence of Patient's Genetic Background in Breast Cancer Treatment.
    Rodrigues R; Duarte D; Vale N
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the computational landscape for repurposed drugs against COVID-19.
    Aronskyy I; Masoudi-Sobhanzadeh Y; Cappuccio A; Zaslavsky E
    Drug Discov Today; 2021 Dec; 26(12):2800-2815. PubMed ID: 34339864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug repositioning trends in rare and intractable diseases.
    Sakate R; Kimura T
    Drug Discov Today; 2022 Jul; 27(7):1789-1795. PubMed ID: 35104621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing antidepressants for anticancer drug discovery.
    Song Y; Yang X; Yu B
    Drug Discov Today; 2022 Jul; 27(7):1924-1935. PubMed ID: 34728374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy.
    Li CL; Fang ZX; Wu Z; Hou YY; Wu HT; Liu J
    Biomed Pharmacother; 2022 Oct; 154():113616. PubMed ID: 36055112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.